OCV Management is a Los Angeles-based venture capital firm specializing in mid-to-late-stage investments. The firm typically participates in Series A through Series D funding rounds, investing in companies with differentiated technologies and compelling target markets. OCV aims to create sustainable long-term value through its investments, focusing on sectors such as technology and life sciences.
Notable portfolio companies include ByHeart, Finch Therapeutics, Precision BioSciences, and Torl Biotherapeutics. The firm is led by key partners who bring extensive experience and a strong network to the table. OCV offers unique value-add services to its portfolio companies, including strategic guidance and operational support to help them scale effectively.
OCV Management - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies10
Follow-on Investments2
Current Portfolio Count10
Top Investment Stages
Series A6 (50.0%)
Series B3 (25.0%)
Series C2 (16.7%)
Series D1 (8.3%)
Stage Mix
Series A 50%Series B 25%Series C 17%Series D 8%
Concentration shown as share of disclosed investments by stage.
OCV Management - Classification
- Also Known As
- OCV Management, LLC
- NAICS
- 520000Finance and Insurance
- 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
- 523900Other Financial Investment Activities
- 523990All Other Financial Investment Activities
- 523999Miscellaneous Financial Investment Activities
- SIC
- 6700Holding And Other Investment Offices
- 6790Miscellaneous Investing
- 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
- NAICS
- 525000Funds, Trusts, and Other Financial Vehicles
- 523910Miscellaneous Intermediation
- 523940Portfolio Management and Investment Advice
- SIC
- 6000Depository Institutions
- 6720Investment Offices
- 6722Management Investment Offices, Open-end
